Cargando…

Improving Pediatric Drug Development: Challenges, Opportunities and Lessons Learned

Detalles Bibliográficos
Autor principal:	Mattison, Donald R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2010
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157972/ http://dx.doi.org/10.3389/fphar.2010.00127

Ejemplares similares

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
por: Biber, Knut, et al.
Publicado: (2019)

Structures, Substrates, and Regulators of Mammalian Sirtuins – Opportunities and Challenges for Drug Development
por: Moniot, Sébastien, et al.
Publicado: (2012)

Editorial: Intranasal Drug Delivery: Challenges and Opportunities
por: Fortuna, Ana, et al.
Publicado: (2022)

Opportunities and Challenges for Drug Development: Public–Private Partnerships, Adaptive Designs and Big Data
por: Yildirim, Oktay, et al.
Publicado: (2016)

Pediatric Drug Development: Challenges and Opportunities
por: Spadoni, Cesare
Publicado: (2018)

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
por: Porta, Exequiel O. J., et al.
Publicado: (2023)

Editorial: Drug-ability strategies for potential antimycobacterial candidate: opportunities and challenges
por: Swain, Shasank Sekhar, et al.
Publicado: (2023)

Editorial: Ethnopharmacology of the lamiaceae: Opportunities and challenges for developing new medicines
por: Panda, Sujogya Kumar, et al.
Publicado: (2022)

Hitchhiking on Controlled-Release Drug Delivery Systems: Opportunities and Challenges for Cancer Vaccines
por: Han, Lu, et al.
Publicado: (2021)

Editorial: Intranasal Delivery of Central Nervous System Active Drugs: Opportunities and Challenges
por: Rodrigues, Márcio, et al.
Publicado: (2022)

The Hungry Stomach: Physiology, Disease, and Drug Development Opportunities
por: Sanger, Gareth J., et al.
Publicado: (2011)

Pharmacogenetics – Challenges and Opportunities Ahead
por: Zanger, Ulrich M.
Publicado: (2010)

Rational use of drugs for the elderly during the COVID-19 pandemic in China: Challenges and opportunities
por: Yin, Qingqing, et al.
Publicado: (2023)

Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile
por: Wang, Ting, et al.
Publicado: (2022)

Lessons Learned from Discontinued Clinical Developments in Duchenne Muscular Dystrophy
por: Markati, Theodora, et al.
Publicado: (2021)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Targeting Autophagy to Treat Cancer: Challenges and Opportunities
por: Lim, Junghyun, et al.
Publicado: (2020)

Editorial: Disease-modifying antirheumatic drugs: Approaches and lessons learned from traditional medicine
por: Mei, Liyan, et al.
Publicado: (2023)

Challenges and opportunities in the development of metal-based anticancer theranostic agents
por: Vaidya, Shreyas P., et al.
Publicado: (2022)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
por: Geng, Meng, et al.
Publicado: (2020)

The Grand Challenges in Cardiovascular Drug Discovery and Development
por: Ohlstein, Eliot H.
Publicado: (2010)

Editorial: Opportunities and challenges in reusing public genomics data
por: Ahmed, Mahmoud, et al.
Publicado: (2023)

Circulating tumor DNA: Opportunities and challenges for pharmacometric approaches
por: Ribba, Benjamin, et al.
Publicado: (2023)

Challenges for Clinical Drug Development in Pulmonary Fibrosis
por: White, Eric S., et al.
Publicado: (2022)

Editorial: Developing Medicines (Drugs) derived from the Asteraceae—an opportunity in ethnopharmacology, Volume II
por: da Silva, Luis Cláudio Nascimento, et al.
Publicado: (2023)

Pediatric Drug Development: Reviewing Challenges and Opportunities by Tracking Innovative Therapies
por: Domingues, Cátia, et al.
Publicado: (2023)

European Socio-Economic Integration: Challenges, Opportunities and Lessons Learned
por: Carayannis, Elias, et al.
Publicado: (2013)

In vitro methods for hazard assessment of industrial chemicals – opportunities and challenges
por: Wong, Chin Lin, et al.
Publicado: (2015)

Editorial: Today's Nutrition and Tomorrow's Public Health: Challenges and Opportunities
por: Lenoir-Wijnkoop, Irene, et al.
Publicado: (2016)

Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities
por: Sharan, Satish, et al.
Publicado: (2015)

Challenges and Opportunities of Nanotechnology as Delivery Platform for Tocotrienols in Cancer Therapy
por: Maniam, Geetha, et al.
Publicado: (2018)

Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart
por: Nassal, Drew, et al.
Publicado: (2020)

New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022
por: Jiang, JingSi, et al.
Publicado: (2022)

Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX Project
por: Pastor, Manuel, et al.
Publicado: (2018)

Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities
por: Chaffey, Laura, et al.
Publicado: (2022)

Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges
por: Zou, Huixi, et al.
Publicado: (2020)

The grand challenges in obstetric and pediatric pharmacology
por: Zajicek, Anne, et al.
Publicado: (2013)

Editorial: Monitoring endogenous GPCRs: lessons for drug design
por: Massotte, Dominique
Publicado: (2015)

The role of drug transporters in the kidney: lessons from tenofovir
por: Moss, Darren M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cd6htrtnrmev3r4p0333giqs83